BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Axsome Therapeutics (NASDAQ:AXSM)

4 posts

Biotech NewsIs Axsome Therapeutics (AXSM) a Smart Long-Term Investment Pick?

  • BioTech Health X
  • March 22, 2026
We recently published our article Top 5 Biotech Stocks That Could Explode in 2026. To read the full…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 5 Biotech Stocks That Could Explode in 2026

  • BioTech Health X
  • March 22, 2026
In this article, we break down the Top 5 Biotech Stocks That Could Explode in 2026. For investors…
0 Shares
0
0
0
0
0
0
0

Biotech NewsWall Street Isn’t Watching This CNS Stock Yet — But Axsome Therapeutics (AXSM) Might Be the Breakout

  • BioTech Health X
  • December 31, 2025
What began as a focused effort to rethink how brain disorders are treated has quietly grown into one…
0 Shares
0
0
0
0
0
0
0

Biotech NewsDon’t Let the 70.7% YTD Jump Fool You—Axsome Therapeutics (AXSM) Still Faces Massive Downside Risk

  • BioTech Health X
  • December 2, 2025
Axsome Therapeutics (NASDAQ:AXSM) is a clinical-stage biopharmaceutical company that has grown into one of the most closely watched…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Here’s Why You Should Keep Ocugen (OCGN) in Your Buy List!
  • Here’s What Makes EyePoint Pharmaceuticals (EYPT) a Great Investment Pick
  • Would You Still Dare to Invest in Viridian Therapeutics (VRDN)?
  • Is it Still Practical to Invest in UroGen Pharma Ltd. (URGN)?
  • Is it a Great Move to Acquire Liquidia Corporation (LQDA) Shares?
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • April 18, 2026
    Here’s Why You Should Keep Ocugen (OCGN) in Your Buy List!
    • April 18, 2026
    Here’s What Makes EyePoint Pharmaceuticals (EYPT) a Great Investment Pick
    • April 18, 2026
    Would You Still Dare to Invest in Viridian Therapeutics (VRDN)?
    • April 18, 2026
    Is it Still Practical to Invest in UroGen Pharma Ltd. (URGN)?
    • April 18, 2026
    Is it a Great Move to Acquire Liquidia Corporation (LQDA) Shares?
Recent Posts
  • Is it Still Safe to Keep on Holding Your Inovio Pharmaceuticals (INO) Shares?
    • April 18, 2026
  • Should You Now Start Buying Cardiol Therapeutics (CRDL) Shares?
    • April 18, 2026
  • Is it Still Safe to Invest in Terns Pharmaceuticals (TERN)?
    • April 18, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (894)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top